Krystal Biotech Inc
KRYS
$330.00-0.21%
End of day · as of Oct 15, 2026, 8:00 PM ET
Mkt cap
$10.17B
EV/Sales
24.9
P/E ratio
N/A
FY2025 Revenue
$389.13M
EPS (TTM)
$7.98
Gross Margin (FY2025)
N/A
Profit Margin (FY2025)
52.64%
Beta
N/A
Div yield
N/A
Sector
Healthcare
Krystal Biotech Inc (KRYS) is a biotechnology company listed on NASDAQ.
Latest reported KRYS revenue for 2025-12-31 was $389.1M. Net income was $204.8M. Revenue was up 33.9% from 2024-12-31 to 2025-12-31. KRYS currently screens at market cap $10.17B.
Use this KRYS research hub for sector, financials, and filings — not a live tape.
Latest cached year on this hub. Full KRYS income, balance, and cash tables.
Krystal Biotech Inc (KRYS) is a biotechnology company in the Healthcare sector.
Latest cached Krystal Biotech Inc (KRYS) revenue for Dec 31, 2025 was $389.1M. Net income was $204.8M. Statements: https://lician.com/financials/krys
Krystal Biotech Inc (KRYS) market capitalization is $10.17B on the latest cached snapshot.
Krystal Biotech Inc (KRYS) cached previous close $330.69; day range $329.87 – $332.98; volume 272,259. Session quote: https://lician.com/quote/krys
Krystal Biotech Inc (KRYS) latest cached earnings event is "KRYS earnings" on Aug 3, 2026. Earnings calendar: https://lician.com/earnings
The latest cached KRYS filing is 8-K · Oct 15, 2026. Filings: https://lician.com/sec/krys